P3 Health Partners Inc. Reaffirmed Earnings Guidance for the full-year ending December 31, 2024. For the year, the company Reaffirming revenue from $1.45 billion to $1.55 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.53 USD | -4.50% | -13.75% | -62.41% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.41% | 85.45M | |
+23.13% | 46.93B | |
+37.49% | 39.08B | |
-8.73% | 38.48B | |
+28.09% | 31.01B | |
-12.26% | 26.14B | |
+10.57% | 25.88B | |
+45.05% | 14.15B | |
+32.23% | 12.53B | |
-6.56% | 11.36B |
- Stock Market
- Equities
- PIII Stock
- News P3 Health Partners Inc.
- P3 Health Partners Inc. Reaffirms Earnings Guidance for the full-year ending December 31, 2024